
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI
[ Thu, Dec 10th 2020 ]: WOPRAI

[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI
[ Wed, Dec 09th 2020 ]: WOPRAI

[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
[ Tue, Dec 08th 2020 ]: WOPRAI
Andrew Berens Maintained (AGIO) at Buy with Decreased Target to $61 on, Dec 9th, 2020


🞛 This publication is a summary or evaluation of another publication
Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Decreased Target from $67 to $61 on, Dec 9th, 2020.
Andrew has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Andrew
- Peter Lawson of "Barclays" Upgraded from Hold to Buy and Held Target at $46 on, Thursday, October 22nd, 2020
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $70 on, Monday, October 19th, 2020